# FDA Inspection 1002599 - Avioq, Inc. - January 13, 2017

Source: https://www.globalkeysolutions.net/records/fda_inspections/avioq-inc/4007711b-1cad-496b-9800-175a9760421a
Source feed: FDA_Inspections

> FDA Inspection 1002599 for Avioq, Inc. on January 13, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1002599
- Company Name: Avioq, Inc.
- Inspection Date: 2017-01-13
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1224168 - 2023-12-05](https://www.globalkeysolutions.net/records/fda_inspections/avioq-inc/f2c7c80a-a712-4173-8498-cea59c9bef05)
- [FDA Inspection 1081335 - 2019-02-27](https://www.globalkeysolutions.net/records/fda_inspections/avioq-inc/de6c4e1a-030f-4fef-9ade-b18227acea08)
- [FDA Inspection 913372 - 2015-01-27](https://www.globalkeysolutions.net/records/fda_inspections/avioq-inc/56023f21-c60a-47a7-b62c-563efa01e2e0)
- [FDA Inspection 819239 - 2013-02-08](https://www.globalkeysolutions.net/records/fda_inspections/avioq-inc/c4b6d351-0217-41e8-a841-98c34422bff2)
- [FDA Inspection 819239 - 2013-02-08](https://www.globalkeysolutions.net/records/fda_inspections/avioq-inc/465a4fce-7faa-4149-9f84-99ab83577116)

Company: https://www.globalkeysolutions.net/companies/avioq-inc/7bf5243a-9d4e-4335-bd22-7d4075729928

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
